Skip to main content
SpringerLink
Log in

Minimum Acceptable Requirements for Introduction and Marketing of Drugs

  • Special Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lasagna, L.: The diseases drugs cause. Perspectives in Biology and Medicine 7: 457–470 (1964).

    PubMed  CAS  Google Scholar 

  2. Blackwell, B.: For the first time in man. Clinical Pharmacology and Therapeutics 13: 812–823 (1972).

    PubMed  CAS  Google Scholar 

  3. Epstein, L.C. and Lasagna, L.: Obtaining informed consent. Form or substance. Archives of Internal Medicine 123: 862–868 (1969)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York, 14642, USA

    Louis Lasagna

Authors
  1. Louis Lasagna
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lasagna, L. Minimum Acceptable Requirements for Introduction and Marketing of Drugs. Drugs 7, 409–413 (1974). https://doi.org/10.2165/00003495-197407060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197407060-00001

Keywords

Search

Navigation